Toggle light / dark theme

Improved blood test offers less invasive way to detect Alzheimer’s disease

A new study in Nature Aging from Lund University in Sweden shows that improved blood tests for the diagnosis of Alzheimer’s disease can now be used with accuracy similar to that of the cerebrospinal fluid tests that have long been the standard in health care. The blood test has been approved for use in Europe, the U.S. and Japan, among other places. The researchers hope that doctors will now gradually be able to use it more widely—and that, in many cases, patients will be able to avoid the more invasive cerebrospinal fluid test.

These new findings are based on cutoff values that directly reflect clinical practice. The results show that this improved blood test, which has previously received FDA approval and CE marking for clinical use, is just as accurate as the established cerebrospinal fluid test—detecting Alzheimer’s disease pathology with at least 90% accuracy.

It is the first time this has been demonstrated, says Noëlle Warmenhoven, a doctoral student in the Clinical Memory Research Unit at Lund University.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.